Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov/Dec;62(6):737-742.
doi: 10.1097/MAT.0000000000000440.

Cannula Design and Recirculation During Venovenous Extracorporeal Membrane Oxygenation

Affiliations

Cannula Design and Recirculation During Venovenous Extracorporeal Membrane Oxygenation

Oscar Palmér et al. ASAIO J. 2016 Nov/Dec.

Abstract

Extracorporeal membrane oxygenation (ECMO) is used as a lifesaving rescue treatment in refractory respiratory or cardiac failure. During venovenous (VV) ECMO, the presence of recirculation is known, but quantification and actions to minimize recirculation after measurement are to date not routinely practiced. In the current study, we investigated the effect of draining cannula design on recirculation fraction (Rf) during VV ECMO; conventional mesh cannula was compared with a multistage cannula. The effect of adjusting cannula position was also studied. Recirculation was measured with ultrasound dilution technique at different ECMO flows and after cannula repositioning. All patients who were admitted to our unit between October 2014 and July 2015 catheterized by the atrio-femoral single lumen method were included. A total of 108 measurements were conducted in 14 patients. The multistage cannula showed significantly less recirculation (19.0 ± 12.2%) compared with the conventional design (38.0 ± 13.7). Pooled data in cases improved from adjustment showing reduced Rf by 7%. In conclusion, the choice of cannula matters, as does adjustment of the draining cannula position during atrio-femoral VV ECMO. By utilizing the ultrasound dilution technique to measure Rf before and after repositioning, effective ECMO flow can be improved for a more effective ECMO treatment.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The different tip designs of the multistage 25 Fr/38 cm (upper cannula) and the conventional mesh 23 Fr/25 cm cannulas. The latter design drains blood through a mesh of holes at the most distal 38 mm (1½″). The multistage cannula has side holes in five segments along the most distal 102 mm (4″).
Figure 2.
Figure 2.
Recirculation fraction to ECMO flow for the conventional (⁃⁃, R2 = 0.581, n = 18) and the multistage cannula (▪⁃▪, R2 = 0.515, n = 40), p < 0.001.
Figure 3.
Figure 3.
Effective ECMO to total ECMO flow from all measurements of the conventional (•/⁃⁃, R2 = 0.263, n = 18) and the multistage cannula (x/▪⁃▪, R2 = 0.750, n = 40), p < 0.05.
Figure 4.
Figure 4.
Pooled distribution data on recirculation fraction at initial 28.5 ± 15.6% (mean ± SD) and after optimization 21.3 ± 13.6% of the draining cannula independent of design (n = 13), p = 0.05.

References

    1. Annich GM, Lynch W, MacLaren G, Wilson J, Bartlett R, editors. ECMO Extracorporeal Cardiopulmonary Support in Critical Care. Ann Arbor, MI: Extracorporeal Life Support Organization; 2012.
    1. Short BL, Williams L, editors. ECMO Specialist Training Manual. Ann Arbor, MI: Extracorporeal Life Support Organization; 2010.
    1. Bennett CC, Johnson A, Field DJ, Elbourne D UK Collaborative ECMO Trial Group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: Follow-up to age 4 years. Lancet. 2001;357:1094–1096. - PubMed
    1. Field D, Davis C, Elbourne D, Grant A, Johnson A, Macrae D. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. UK Collaborative ECMO Trail Group. Lancet. 1996;348:75–82. - PubMed
    1. Peek GJ, Mugford M, Tiruvoipati R, et al. CESAR Trial Collaboration. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicentre randomised controlled trial. Lancet. 2009;374:1351–1363. - PubMed